diabetestalk.net

Prevention Of Diabetes Mellitus Type 1

Prevention Of Diabetes Mellitus

Prevention Of Diabetes Mellitus

Tweet When people talk about prevention of diabetes, it is usually about preventing type 2 diabetes. In the majority of cases, type 2 diabetes is brought on by lifestyle factors which can often be prevented. These include an unbalanced diet, lack of activity, lack of sleep, stress, smoking and alcohol. By making lifestyles changes, you can decrease your risk of developing type 2 diabetes. Type 2 diabetes prevention overview Leading doctors and researchers point to excessive levels of insulin as the likely reason why insulin resistance and type 2 diabetes develops. Strategies such as low-carb diets and exercise help to reduce levels of insulin and are therefore effective for preventing type 2 diabetes from developing. There are a number of risk factors for diabetes, some of which are preventable, such as weight gain around the middle (central obesity), high cholesterol/triglyceride levels and high blood pressure. Losing weight, adopting more activity into your day, stopping smoking and reducing alcohol intake can also help towards lowering the risk of developing type 2 diabetes mellitus and improving your all-round health. Diet and preventing type 2 diabetes Diet is the most important part of lifestyle change. The adage that you can’t outrun a bad diet is true. It is much easier to lose weight on a good diet even if you are struggling to do exercise, than it is through exercise if you’re eating a poor diet. Effective diets to prevent type 2 diabetes are those that do not cause your body to produce a lot of insulin. Carbohydrate has the biggest demand on insulin and so any diet that helps reduce carbohydrate intake will help towards reducing your risk of type 2 diabetes. Cutting out sugary food and drink and refined grains such as white bread and white rice is a good Continue reading >>

Can Diabetes Be Prevented?

Can Diabetes Be Prevented?

en espaolSe puede prevenir la diabetes? Diabetes is a disease that affects how the body uses glucose , the main type of sugar in the blood. Glucose, which comes from the foods we eat, is the major source of energy needed to fuel the body. To use glucose, the body needs the hormone insulin . But in people withdiabetes, the body either can't make insulin or the insulin doesn't work in the body like it should. Type 1 diabetes, in which the immune system attacks the pancreas and destroys the cells that make insulin. Type 2 diabetes, in which the pancreas can still make insulin, but the body doesn't respond to it properly. In both types of diabetes, glucose can't get into the cells normally. This causes a rise in blood sugar levels , which can make someone sick if not treated. Type 1 diabetes can't be prevented. Doctors can't even tell who will get it and who won't. No one knows for sure what causes type 1 diabetes, but scientists think it has something to do with genes . But just getting the genes for diabetes isn't usually enough. In most cases, a child has to be exposed to something else like a virus to get type 1 diabetes. Type 1 diabetes isn't contagious, so kids and teens can't catch it from another person or pass it along to friends or family members. And eating too much sugar doesn't cause type 1 diabetes, either. There's no reliable way to predict who will get type 1 diabetes, but blood tests can find early signs of it. These tests aren't done routinely, however, because doctors don't have any way to stop a child from developing the disease, even if the tests are positive. Unlike type 1 diabetes, type 2 diabetes can sometimes be prevented. Excessive weight gain, obesity , and a sedentary lifestyle are all things that put a person at risk for type 2 diabetes. In the Continue reading >>

9 Ways To Prevent Type 1 Diabetes Complications

9 Ways To Prevent Type 1 Diabetes Complications

How to Master Type 1 Diabetes Management Having type 1 diabetes puts you at greater risk for a number of health complications including infection, kidney failure, and blindness. But by controlling your blood sugar, you can prevent or delay the onset of many of these complications. Making healthy lifestyle changes, such as eating a healthy diet and exercising regularly, and taking your diabetes medications as prescribed can help you manage your blood sugar. Need a target goal? Your A1C, the blood test that indicates your average blood sugar over a three-month period, is an excellent starting point. "If you keep your A1C under 7, it will help prevent complications," says Sarfraz Zaidi, MD, director of the Jamila Diabetes and Endocrine Medical Center and an endocrinologist at Los Robles Hospital and Medical Center in Thousand Oaks, Calif. Continue reading >>

Primary And Secondary Prevention Of Type 1 Diabetes

Primary And Secondary Prevention Of Type 1 Diabetes

Primary and secondary prevention of Type 1 diabetes Division of Endocrinology, Diabetes and Metabolism and Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA J. S. Skyler, Division of Endocrinology, Diabetes and Metabolism and Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA; The publisher's final edited version of this article is available at Diabet Med See other articles in PMC that cite the published article. Type 1 diabetes is thought to be an immunologically mediated disease, the end result of which is pancreatic islet -cell destruction [ 1 , 2 ]. Other articles in this review issue address the origins of the disease, including the immunogenotype and the role of environmental factors responsible for initiating the immune response. That initial immune response may engender additional secondary and tertiary responses, which collectively result in impairment of -cell function, progressive destruction of -cells and consequent evolution of Type 1 diabetes. This insidious process evolves over a variable amount of timeeven many years in some individuals. The eventual overt manifestation of clinical symptoms becomes apparent only when most -cells have lost function and presumably have been destroyed. If Type 1 diabetes is an immunologically mediated disease, then immune intervention should alter the natural history of the disease and potentially abrogate the clinical syndrome. The evidence that an immune mechanism may be important in the aetiopathogenesis of human Type 1 diabetes, coupled with the success of immune intervention in animal models, has led to clinical trials of various immune intervention therapies in Type 1 diabetes. Although prevention of Type 1 diabetes is the logical ultima Continue reading >>

Prevention Of Type 1 Diabetes

Prevention Of Type 1 Diabetes

Type 1 diabetes is a chronic autoimmune condition characterized by destruction of insulin-producing β cells within the pancreatic islets. It is associated with considerable morbidity and mortality. Incidence levels are rising worldwide. The causes of disease are multifactorial with genetic and environmental factors playing a part. There is a long pre-clinical period before the onset of overt symptoms, which may be amenable to therapeutic intervention to prevent disease. Continue reading >>

Prevention Of Diabetes Mellitus Type 2

Prevention Of Diabetes Mellitus Type 2

Main article: Diabetes mellitus type 2 Prevention of diabetes mellitus type 2 can be achieved with both lifestyle changes and use of medication.[1] The American Diabetes Association categorizes prediabetes as a high-risk group that has glycemic levels higher than normal but does not meet criteria for diabetes. Without intervention people with prediabetes progress to type 2 diabetes with a 5% to 10% rate. Diabetes prevention is achieved through weight loss and increased physical activity, which can reduce the risk of diabetes by 50% to 60%.[2] Lifestyle[edit] Many interventions to promote healthy lifestyles have been shown to prevent diabetes. A combination of diet and physical activity promotion through counselling and support programs decrease weight, improve systolic blood pressure, improve cholesterol levels and decrease risk of diabetes.[2] Increasing physical activity may be helpful in preventing type 2 diabetes, particularly if undertaken soon after a carbohydrate rich meal that increases blood sugar levels.[3][4][5] The American Diabetes Association (ADA) recommends maintaining a healthy weight, getting at least 2½ hours of exercise per week (several brisk sustained walks appear sufficient), having a modest fat intake (around 30% of energy supply should come from fat), and eating sufficient fiber (e.g., from whole grains). Some preliminary evidence suggests that resistant starch, used as a substitute for refined carbohydrate, may increase insulin sensitivity[6] and may reduce the risk of type 2 diabetes.[7] The U.S. Food and Drug Administration requires claims that resistant starch can reduce the risk of type 2 diabetes to be qualified with a declaration that scientific evidence in support of this claim is limited.[8] Foods with low glycemic index rich in fiber Continue reading >>

Prevention Of Type 1 Diabetes Mellitus

Prevention Of Type 1 Diabetes Mellitus

INTRODUCTION The increase in understanding of the pathogenesis of type 1 diabetes mellitus (formerly known as insulin-dependent diabetes mellitus) has made it possible to consider intervention to slow the autoimmune disease process in an attempt to delay or even prevent the onset of hyperglycemia. This topic will review current and planned efforts to prevent type 1 diabetes. Subjects who are at high risk for type 1 diabetes can be identified using a combination of immune, genetic, and metabolic markers. (See "Prediction of type 1 diabetes mellitus".) In the current classification of diabetes, immune-mediated type 1 diabetes is called type 1A to distinguish it from less common cases in which an autoimmune etiology cannot be determined (type 1B); the latter are said to be idiopathic [1]. The term type 1 diabetes used here refers to type 1A, or autoimmune diabetes. (See "Classification of diabetes mellitus and genetic diabetic syndromes".) PREVENTION AND REVERSAL STRATEGIES Several immunosuppressive and immunomodulatory agents and other drugs have been given either alone or in combination to decrease the immune-mediated destruction of beta cells that occurs in type 1 diabetes [2]. Most of the studies have been performed in recent-onset diabetes, where the majority of beta-cell function has already been lost, and the anticipated outcome is preservation of remaining beta-cell function, usually measured as area under the curve (AUC) insulin secretion in response to stimulation. Many of the studies involve small numbers of patients and are uncontrolled. Immunomodulators Azathioprine — Azathioprine is an immunosuppressive drug that inhibits or prevents T cell responses to antigens. In one randomized, double-blind study of 46 patients treated with azathioprine and glucocortico Continue reading >>

Type 1 Diabetes

Type 1 Diabetes

Currently there is no way to prevent , but ongoing studies are exploring ways to prevent diabetes in those who are most likely to get it. People who have a parent, brother, or sister with type 1 diabetes and are willing to participate in one of these studies should talk with their doctors. People who have type 1 diabetes can help prevent or delay the development of complications by keeping their blood sugar in a target range. They also need regular medical checkups to detect early signs of complications. If complications are treated early, the damage may be stopped, slowed, or possibly reversed. People who have other health problems along with diabetes, such as high blood pressure or high cholesterol, need to treat those conditions. Also, not smoking can reduce the risk of complications. Having other health problems can increase the risk for complications from diabetes. Get a flu vaccine every year. When you have the flu, it can be harder to manage your blood sugar. It's a good idea to get a pneumococcal vaccine for pneumonia and a vaccine for hepatitis B. You may need or want additional immunizations if certain situations raise your chance for exposure to disease. Continue reading >>

Prediction And Prevention Of Type 1 Diabetes Mellitus

Prediction And Prevention Of Type 1 Diabetes Mellitus

Abstract Type 1A diabetes mellitus (T1DM) is caused by autoimmune islet β-cell destruction with consequent severe insulin deficiency. We can now predict the development of T1DM by determining four biochemically characterized islet autoantibodies, namely those antibodies against insulin, glutamic acid decarboxylase 65, insulinoma antigen (IA)-2 (ICA512) and the zinc transporter ZnT8. We can also prevent T1DM in animal models, but the final goal is the prevention of T1DM in humans. Multiple clinical trials are underway investigating methods to prevent β-cell destruction. Introduction Type 1A diabetes mellitus (T1DM) is characterized by autoimmune-mediated selective destruction of pancreatic β-cells, with consequent severe insulin deficiency. There are other forms of insulin-deficient diabetes, including monogenic forms.1 T1DM is commonly diagnosed in children and adolescents, but can occur at any age. T1DM presents with hyperglycemia and usually a need for immediate exogenous insulin treatment. The incidence of T1DM in many developed countries is now twice as high among children as it was in the 1980s.2,3 In north Italy, the overall incidence rate from 1984 to 2004 in the 0–29 years age group has been reported to be 11.3/100 000 person-years.4 Furthermore, both the 0–14 and 15–29 year age groups had a 60% higher risk in 2000–2004 compared with the period 1984–1989.5 During the past two decades, improved understanding of the natural history and pathogenesis of T1DM have led to the ability to predict the disease in humans and to prevent it in animal models. Clinical trials for the prevention of T2DM in humans are underway. Prediction of diabetes Anti-islet autoimmunity precedes the development of T1DM (usually by years) and is associated with progressive metabo Continue reading >>

Diabetes Mellitus Type 1

Diabetes Mellitus Type 1

Diabetes mellitus type 1 (also known as type 1 diabetes) is a form of diabetes mellitus in which not enough insulin is produced.[4] This results in high blood sugar levels in the body.[1] The classical symptoms are frequent urination, increased thirst, increased hunger, and weight loss.[4] Additional symptoms may include blurry vision, feeling tired, and poor healing.[2] Symptoms typically develop over a short period of time.[1] The cause of type 1 diabetes is unknown.[4] However, it is believed to involve a combination of genetic and environmental factors.[1] Risk factors include having a family member with the condition.[5] The underlying mechanism involves an autoimmune destruction of the insulin-producing beta cells in the pancreas.[2] Diabetes is diagnosed by testing the level of sugar or A1C in the blood.[5][7] Type 1 diabetes can be distinguished from type 2 by testing for the presence of autoantibodies.[5] There is no known way to prevent type 1 diabetes.[4] Treatment with insulin is required for survival.[1] Insulin therapy is usually given by injection just under the skin but can also be delivered by an insulin pump.[9] A diabetic diet and exercise are an important part of management.[2] Untreated, diabetes can cause many complications.[4] Complications of relatively rapid onset include diabetic ketoacidosis and nonketotic hyperosmolar coma.[5] Long-term complications include heart disease, stroke, kidney failure, foot ulcers and damage to the eyes.[4] Furthermore, complications may arise from low blood sugar caused by excessive dosing of insulin.[5] Type 1 diabetes makes up an estimated 5–10% of all diabetes cases.[8] The number of people affected globally is unknown, although it is estimated that about 80,000 children develop the disease each year.[5] With Continue reading >>

Prevention Of Type 1 Diabetes Mellitus

Prevention Of Type 1 Diabetes Mellitus

Type 1 diabetes mellitus is an autoimmune disease. Although the process by which the pancreatic β-cell is destroyed is not well understood, several risk factors and immune-related markers are known that accurately identify many first-degree relatives of patients with type 1 diabetes who will develop the disease. Because we now have the ability to predict the development of type 1 diabetes in some people, investigators have begun to explore the use of intervention therapy to halt or even prevent β-cell destruction in such individuals. STATEMENT General information Sufficient data exist to warrant intervention studies for the prevention of type 1 diabetes. Intervention for the prevention of type 1 diabetes should be attempted only in the context of defined clinical studies with Institutional Review Board oversight. Intervention studies for the prevention of type 1 diabetes are best accomplished by randomized controlled studies. A registry of intervention studies should be maintained, and all planned studies should be reported to a coordinating body. Screening Screening of any population is discouraged outside the context of defined research studies. Screening of high-risk individuals (e.g., first-degree relatives of type 1 diabetic patients) should be encouraged, providing that individuals who screen positive are referred to centers participating in cooperative intervention studies or other scientific investigations. Information about ongoing studies should be easily obtainable. All patients screened and not entered into a study should be counseled as to their risk of diabetes, and follow-up should be offered. Screening by determining HLA type is not currently warranted outside the context of defined research studies. An NIH-sponsored multicenter study, the Diabetes Pre Continue reading >>

Secondary Prevention Of Type 1 Diabetes Mellitus: Stopping Immune Destruction And Promoting ß-cell Regeneration

Secondary Prevention Of Type 1 Diabetes Mellitus: Stopping Immune Destruction And Promoting ß-cell Regeneration

C.E.B. Couri1, M.C. Foss1 and J.C. Voltarelli2 1Divisão de Endocrinologia and Metabologia, 2Divisão de Imunologia Clínica e Unidade de Transplante de Medula Óssea, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil Type 1 diabetes mellitus results from a cell-mediated autoimmune attack against pancreatic ß-cells. Traditional treatments involve numerous daily insulin dosages/injections and rigorous glucose control. Many efforts toward the identification of ß-cell precursors have been made not only with the aim of understanding the physiology of islet regeneration, but also as an alternative way to produce ß-cells to be used in protocols of islet transplantation. In this review, we summarize the most recent studies related to precursor cells implicated in the regeneration process. These include embryonic stem cells, pancreas-derived multipotent precursors, pancreatic ductal cells, hematopoietic stem cells, mesenchymal stem cells, hepatic oval cells, and mature ß-cells. There is controversial evidence of the potential of these cell sources to regenerate ß-cell mass in diabetic patients. However, clinical trials using embryonic stem cells, umbilical cord blood or adult bone marrow stem cells are under way. The results of various immunosuppressive regimens aiming at blocking autoimmunity against pancreatic ß-cells and promoting ß-cell preservation are also analyzed. Most of these regimens provide transient and partial effect on insulin requirements, but new regimens are beginning to be tested. Our own clinical trial combines a high dose immunosuppression with mobilized peripheral blood hematopoietic stem cell transplantation in early-onset type 1 diabetes mellitus. Key words: Diabetes Continue reading >>

Prevention Of Type 1 Diabetes

Prevention Of Type 1 Diabetes

Go to: INTRODUCTION Type 1 diabetes is an autoimmune disease in which the β cells of the pancreatic islets are destroyed rendering the individual increasingly incapable of mounting a normal insulin response to ingested nutrients1, 2. In the early 1980's Eisenbarth enunciated the main phases in the pathogenesis of type 1 diabetes (figure 1), a framework which continues to be useful in considering approaches to the prevention or cure of this disorder2: susceptibility to T1D is inherited through a series of genes, the most important of which relate to the HLA class II-locus on chromosome 6, with lesser contribution from a number of others, including the insulin gene, CTLA4 and others (see below). Susceptibility genes are essential, but insufficient in explaining the immune pathogenesis of TID, i.e. the majority of individuals with these susceptibility genes never develop the disorder. exposure to one or more environmental trigger(s) alters the immune system in such a way that susceptibility is converted to pathophysiology and destruction of β cells begins. Despite intensive searches for environmental triggers, the number of candidates being assessed in clinical trials remains quite small, e.g. cow's milk proteins, relative lack of vitamin D and supplementation with omega 3 fatty acids3-7. while attack on the β cells is mediated in large part by T cells, it is the presence of humoral (B cell) markers that punctuates the next phase: normal glucose homeostasis in the presence of one or more T1D-specific autoantibodies, ICA512/IA-2, IAA and GAD are the main ones available for measurement. The progression to clinical TID is highly predictable based on the number of antibodies present8. the earliest metabolic abnormality detected is loss of first phase insulin secretion in re Continue reading >>

Type 1 Diabetes

Type 1 Diabetes

Type 1 diabetes (previously called insulin-dependent or juvenile diabetes) is usually diagnosed in children, teens, and young adults, but it can develop at any age. If you have type 1 diabetes, your pancreas isn’t making insulin or is making very little. Insulin is a hormone that enables blood sugar to enter the cells in your body where it can be used for energy. Without insulin, blood sugar can’t get into cells and builds up in the bloodstream. High blood sugar is damaging to the body and causes many of the symptoms and complications of diabetes. Type 1 diabetes is less common than type 2—about 5% of people with diabetes have type 1. Currently, no one knows how to prevent type 1 diabetes, but it can be managed by following your doctor’s recommendations for living a healthy lifestyle, controlling your blood sugar, getting regular health checkups, and getting diabetes self-management education. Shakiness Nervousness or anxiety Sweating, chills, or clamminess Irritability or impatience Dizziness and difficulty concentrating Hunger or nausea Blurred vision Weakness or fatigue Anger, stubbornness, or sadness If your child has type 1 diabetes, you’ll be involved in diabetes care on a day-to-day basis, from serving healthy foods to giving insulin injections to watching for and treating hypoglycemia (low blood sugar; see below). You’ll also need to stay in close contact with your child’s health care team; they will help you understand the treatment plan and how to help your child stay healthy. Much of the information that follows applies to children as well as adults, and you can also click here for comprehensive information about managing your child’s type 1 diabetes. Causes Type 1 diabetes is caused by an autoimmune reaction (the body attacks itself by mistak Continue reading >>

Current Approaches To The Prevention Of Type 1 Diabetes

Current Approaches To The Prevention Of Type 1 Diabetes

As well as investigating therapies that interrupt the autoimmune process leading to type 1 diabetes, researchers are looking at ways to preserve endogenous insulin production in patients newly diagnosed with the disease. Type 1 diabetes is usually the result of T cell - mediated autoimmune destruction of the insulin-producing beta cells of the pancreas. Canada has one of the highest reported incidence rates of type 1 diabetes in the world. Both genetic and environmental factors are felt to be important in the initiation and development of this disease. The risk for developing type 1 diabetes can now be predicted with accuracy using a combination of tests, including the quantitation of beta cell autoantigens, HLA genotyping, and dynamic measures of beta cell function. The ability to identify high-risk populations has led to the development of a number of experimental treatments designed to interrupt the initiation or progression of the autoimmune process (primary prevention), or to preserve endogenous insulin production in new-onset type 1 diabetes (secondary prevention). Type 1 diabetes (T1D, previously called insulin-dependent or juvenile diabetes) is usually the result of T cell - mediated autoimmune destruction of the insulin-producing beta cells of the pancreas.[1] While T1D affects males and females equally, there are very significant worldwide variations in prevalence, with people of European descent being most affected. Recent estimates of the incidence of this disease in Canada suggest an annual rate of 20 to 26 new cases per 100 000 children aged 0 to 14 years, among the highest reported in the world.[2] The prevalence of T1D (using 1990 American data) is estimated at 0.19%, or about 1 in 500 children aged 0 to 19 years.[3] This corresponds with our centre’s Continue reading >>

More in diabetes